This Newsletter covers Federal and State policy and legislative developments in the area of health. Copies of documents referred to can be obtained by clicking on the reference in this Newsletter or through Capital Monitor's collection at www.capitalmonitor.com.au or from the source quoted.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
31 August
Provision of industry data to the Independent Hospital Pricing Authority
This circular is to advise that the Department of Health (the department) has issued requests for device level data from the medical technology industry to enable the Independent Hospital Pricing Authority (IHPA) to provide advice to the department on the benchmark price for prostheses in the public sector as a part of the Prostheses List (PL) reforms announced in the 2021-22 Federal Budget. Requests were sent in August 2021 through industry bodies (AusBiotech and Medical Technology Association of Australia) as well as directly to companies via email.
Download
30 August
He Absolute King sachets
The Therapeutic Goods Administration (TGA) tested a product labelled He Absolute King and found that:
- The sachets contain the undeclared substance Tadalafil.
Consumers are advised that Tadalafil are prescription-only substances in Australia. The supply of He Absolute King sachets containing undisclosed Tadalafil is illegal. He Absolute King sachets have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
Download
PHI 55/21 Hospital and Second-tier Updates
The Department of Health said that hospital update and second-tier benefits eligibility announcement. The following hospitals' names and/or addresses have been updated following confirmation from the state authority:
Previous Hospital Name: Northern Cancer Institute
New Hospital name: GenesisCare North Shore
Previous address: Level 1, 38 Pacific Highway, St Leonards NSW 2065
Updated address: 7 Westbourne Street, St Leonards NSW 2065
Provider number: 0027320F
Download
Advice on the use of tocilizumab (Actemra) intravenous vials post expiry date during the COVID-19 pandemic
Due to the current shortages of tocilizumab (Actemra) and the current COVID-19 pandemic, the Therapeutic Goods Administration (TGA) advised that they have assessed that tocilizumab vials continue to be stable for a further six months past their labelled expiry date. Roche Products Pty Limited (Roche), the sponsor of tocilizumab (Actemra), has notified the TGA that the shortage of tocilizumab intravenous vials will continue until January 2022.
Download
Minocycline and agranulocytosis
The Department of Health said that Minocycline is a tetracycline antibiotic that may be used to treat acne that is resistant to other antibiotics, as well as various other susceptible infections. It is marketed in Australia under the tradename Minomycin and the generic brand Akamin. Cases of agranulocytosis have been reported to the Therapeutic Goods Administration (TGA) following treatment with minocycline. As at 25 August 2021, the TGA had recorded reports of 4 cases for minocycline involving agranulocytosis.
Download
29 August
Breakthrough PBS listings to benefit thousands of Australians
From 1 September 2021, thousands of Australians living with schizophrenia, liver disease, lymphoma and anaphylaxis will have access to new treatments through new and amended listings on the Pharmaceutical Benefits Scheme (PBS), said Minister for Health and Aged Care Greg Hunt. For the first time, Australians with schizophrenia will have access to the antipsychotic Reagila (cariprazine). Schizophrenia is a serious mental health condition with a wide range of symptoms and affects about 1 in 100 people.
Download
Return to top
Research
3 September
New resource to advance genomics-driven precision medicine
By analysing genomic data from more than 30,000 people, an international team has revealed thousands of new regulatory regions that control disease-linked genes - a resource that is now available to researchers worldwide. The findings, co-led by the Garvan Institute of Medical Research and published in Nature Genetics, are a significant step forward for genomics-driven precision medicine and could help identify markers that reveal which patients will benefit most from which treatment.
Download
1 September
Prof Shane Grey to lead gene therapy for type 1 diabetes
To continue his pioneering work in finding new approaches to treat type 1 diabetes (T1D), Professor Shane Grey has been awarded a significant grant by JDRF, the leading global funder of type 1 diabetes research. He will lead a collaborative team to develop viral vectors aimed at protecting insulin producing cells in the pancreas from immune destruction and thereby restoring production of insulin - a hormone that is central to controlling blood sugar regulation. If successful, the approach could reduce T1D patients' reliance on daily injections and help prevent some of the significant disease side effects, said Garvan Institute of Medical Research.
Download
30 August
Gut instinct could see you fall for COVID misinformation
People who think based on their first instincts are more likely to believe and share COVID-19 misinformation, according to new research from the Australian National University (ANU). The study compared intuitive thinkers, those who tend to make decisions on immediate instinct, with reflective thinkers, or those who stop and reflect on the accuracy of information presented to them. As part of the study, 742 Australians were shown a mix of five already debunked COVID-19 claims and five accurate statements from public health authorities.
Download
Over half of Australians support ending retail sales of cigarettes within 10 years
Support for phasing out the sale of cigarettes is common among Victorian adults, according to a study published by the Medical Journal of Australia. Almost two-thirds think the retail sale of cigarettes should be phased out within 10 years. 'A total of 1466 respondents (52.8%) - including 145 of 457 current smokers (31.7%), 367 of 682 adults under 30 years of age (53.8%) and 599 of 1122 adults aged 50 or more (53.4%) - thought it would be good were selling cigarettes in retail outlets phased out; 533 (19.2%), including 181 smokers (39.6%), thought it would be bad.
Download
Monthly data
The Australian Institute of Health & Welfare (AIHW) said it receives and aggregates data from around 1,600 specialist homelessness services agencies across Australia on a monthly basis. This site presents monthly data on the number of clients supported throughout each month since July 2017, by state, age and sex. Additional breakdowns by specific target groups, the reasons clients sought assistance, homelessness status, clients receiving financial support for short-term accommodation and nights in short-term accommodation are also included.
Download
Return to top
Rural, Regional and Remote Health
2 September
Distribution Priority Areas exceptional circumstances review for GPs
A new exceptional circumstance review for the Department of Health's Distribution Priority Area (DPA) classification will help regional and rural areas respond to unforeseen workforce and population changes which may be impacting access to local GP services. Federal Minister for Regional Health David Gillespie said the DPA classification allows government to identify regions where locals face an increased challenge to access a GP. The DPA system assesses regions annually, using the most up to date available data to support approvals for priority access to internationally-trained doctors and bonded doctors.
Download
1 September
Extra Pfizer doses will assist rural vax rollout
The Rural Doctors Association of Australia (RDAA) has welcomed an announcement from the Federal Government that it will roll out an additional 500,000 doses of the Pfizer vaccine across Australia in the coming weeks, following a vaccine swap with Singapore. 'The fact that the doses are being distributed across Australia on a per capita basis will mean more rural general practices should be able to provide Pfizer jabs going forward' RDAA President, Dr John Hall, said.
Download
Return to top
Women's Health
30 August
National surgical abortion rate drops by 5.1% Per year
The rate of surgical abortions nationally has declined by 5.1% per year since the listing of mifepristone/misoprostol (medical abortion) on the Pharmaceutical Benefits Scheme in 2013, according to research published by the Medical Journal of Australia. 'It is difficult to estimate the abortion rate in Australia, as most states do not routinely report abortion data and published national data have been incomplete,' wrote the authors, led by Dr Louise Keogh, a health sociologist at the University of Melbourne's Centre for Health Equity. 'Consequently, some clinicians and academics have been accused of inflating reported rates for political reasons.'
Download
10 years between colonoscopies reduces surveillance benefits by 60%
Extending the recommended time between surveillance colonoscopies from 5 years to 10 years for people who have had precursor lesions, such as polyps, removed may increase the risk of advanced neoplasia by 60%, according to research by the Medical Journal of Australia. 'Until recently, the Australian guidelines recommended surveillance colonoscopy 5 years after a finding of non advanced adenoma, but follow-up at 10 years is now recommended for most patients,' wrote the researchers, led by Dr Zaki Hamarneh, from Flinders Medical Centre in Adelaide, and colleagues. 'The evidence supporting the change in timing is limited.'
Download
27 August
Final hearing focussed on women's mental health
The House Select Committee on Mental Health and Suicide Prevention will hold its final public hearing via videoconference on Friday, 27 August 2021, with a focus on the mental health concerns and systems that impact women. From 6-10 September 2021 is Women's Health Week - a nation-wide campaign of events and online activities dedicated to all women across Australia to make good health a priority. Chair, Dr Fiona Martin MP, said 'The Committee commends the work of Jean Hailes in continuing Women's Health Week. When we support women in accessing mental health care, as and when they need it, we improve women's overall health, boost women's participation in the workforce, and support Australian families.'
Download
Return to top
Transcripts
Minister for Finance Simon Birmingham and Deputy Leader of the Australian Labor Party Richard Marles
03 SEP: Transcript of Interview with Karl Stefanovic, The Today Show
Subjects: Queensland Premier, National plan, Delta variant, Vaccine targets, AMA, Health system, Vaccine rollout
Treasurer Josh Frydenberg
02 SEP: Transcript of Interview with Neil Mitchell, 3AW
Subjects: Lockdowns, Vaccine rollout, Economy, Victoria, Vaccination rate, Open up, Small business, Mental health, Western Australia
Minister for Health Greg Hunt
02 SEP: Transcript of Press Conference, Canberra
Subjects: Vaccination rollout, National plan, COVID response, Under 12s, Over 60s, Queensland, Delta variant, Mandatory vaccination, Aged care workers
Minister for Employment, Workforce, Skills, Small and Family Business, Stuart Robert
02 SEP: Transcript of Interview with Peter Stefanovic, Sky News
Subjects: QLD Premier, National Plan, COVID-19, Children, Melbourne lockdown, Vaccines, AstraZeneca
Department of Health
02 SEP: Transcript of Chief Nursing and Midwifery Officer, Professor Alison McMillan, Interview with Ray Hadley, 2GB
Subjects: COVID-19, Lockdown, Vaccines, AstraZeneca, Moderna, Pfizer
Australian Medical Association (AMA)
02 SEP: Transcript of Doorstop Interview with President, Dr Omar Khorshid
Subjects: Preparing hospitals, Opening up, Vaccinating children aged under 12, Mandatory vaccination, Healthcare workers, Over 60s
Leader of the Australian Labor Party Anthony Albanese
02 SEP: Transcript of Doorstop Interview, Parliament House, Canberra
Subjects: COVID-19, Pandemic, Lockdowns, Outbreaks, Border closures, Vaccine rollout, Immunisation, Doherty modelling, Vaccinating young children
Shadow Treasurer Jim Chalmers
02 SEP: Transcript of Interview with Fran Kelly, RN Breakfast
Subjects: National Accounts, Australia's economy slowing, Prime Minister, Quarantine, Vaccine rollout, National plan, Borders and vaccinations, Queensland Premier
Shadow Minister for Health and Ageing Mark Butler
02 SEP: Transcript of Doorstop Interview, Adelaide
Subjects: COVID cases and deaths, Hospital capacity, State Premiers, National plan to reopen, Teenage vaccines, Mandatory vaccines for hospital workers, Under 12 vaccines
Shadow Minister for Industrial Relations Tony Burke
02 SEP: Transcript of Interview with Laura Jayes, Sky News
Subjects: Vaccination rollout, National Cabinet plan, State border closures, Queensland Premier, Vaccination rate, Hospital system
Shadow Cabinet Secretary Jenny McAllister
02 SEP: Transcript of Interview with Peter Stefanovic, Sky News First Edition
Subjects: Lockdown, COVID-19, Pandemic, Public health, Vaccination, Immunisation, Respect at Work, Women, Border closures, Economy
Deputy Chair, Joint Standing Committee Of Public Accounts And Audit Julian Hill
02 SEP: Transcript of Doorstop Interview, Parliament House
Subjects: Prime Minister, Vaccine rollout, Quarantine facilities, JobKeeper, State border closures, Economic management, Mental health in young people
Attorney-General Michaelia Cash
01 SEP: Transcript of Interview with David Lipson and Sabra Lane, ABC AM Program
Subjects: State border closures, Western Australia, National plan, Vaccine rollout, High Court, Vaccine targets
Leader of the Australian Labor Party Anthony Albanese
01 SEP: Transcript of Interview with Stav Davidson, Abby Coleman & Matty Acton, B105 Brisbane
Subjects: COVID outbreaks and restrictions around Australia, Lockdowns, Food during lockdown, NRL, Vaccine rollout, Vaccination rates
Leader of the Australian Labor Party Anthony Albanese
01 SEP: Transcript of Interview with Tanya Wilks, Triple M
Subjects: $300 COVID-19 vaccination incentive, COVID outbreaks, Vaccine rollout, Fitness regimes, Anti-lockdown protests, NSW, VIC
Deputy Leader of the Australian Labor Party Richard Marles
01 SEP: Transcript of Interview with Marcus Paul, 2SM
Subjects: AFL Grand final, Vaccine rollout, National plan, Paralympics, Vaccination rates
Shadow Minister for the National Disability Insurance Scheme Bill Shorten
01 SEP: Transcript of Interview with Liam Bartlett, 6PR Perth
Subjects: Federal Government overstating NDIS costs, Companies receiving JobKeeper, Federal Opposition leadership, NDIS, Dementia
Member for Macquarie Susan Templeman
01 SEP: Transcript of Doorstop Interview, Parliament House, Canberra
Subjects: Youth mental health services, Maari Ma Aboriginal Corporation, Vaccine rollout, Vaccination rates, Headspace, Vaccinations in Aboriginal communities
Prime Minister Morrison
31 AUG: Transcript of Interview with Mike O'Loughlin, Tasmania Talks
Subjects: Lockdowns, Delta strain, Vaccination rates, National Plan, Doherty modelling, Vaccine rollout, State health advice
Shadow Assistant Minister for Health Shadow Assistant Ged Kearney
31 AUG: Transcript of Interview with Jade MacMillan, ABC Capital Hill
Subjects: Singapore vaccine swap, Vaccine rollout, PM, Pfizer, Pharmaceutical companies, Hospitals, Health clinics
Prime Minister Scott Morrison, Minister for Foreign Affairs Marise Payne and Minister for Health Greg Hunt
31 AUG: Transcript of Press Conference, Canberra
Subjects: Vaccines, Vaccination program, Quarantine, Public health, GPs, Poland, Singapore, Pfizer
Australian Medical Association (AMA)
31 AUG: Transcript of President, Dr Omar Khorshid's Doorstop Interview, WA
Subjects: Mandatory vaccinations, Healthcare system, NSW, COVID-19, Health workers, WA, Mining, Indigenous communities, Regional health
Treasurer Josh Frydenberg
30 AUG: Transcript of Interview with Karl Stefanovic, The Today Show
Subjects: State lockdowns, Vaccine rollout, Economic support, Small business support, JobKeeper, Recession, State Premiers, National plan for reopening
Treasurer Josh Frydenberg
30 AUG: Transcript of Interview with Peter Stefanovic, Sky News First Edition
Subjects: State lockdowns, National Accounts, State Premiers, National plan for reopening, Doherty Institute modelling, Mental health in young people
Minister for Employment, Workforce, Skills, Small and Family Business Stuart Robert
30 AUG: Transcript of Interview with Triple M's Gus Worland and Allison Langdon, The Today Show
Subjects: Truckies protest in Queensland, Australia's vaccination rollout, National Plan for reopening, Vaccinations for children
Assistant Minister for Youth and Employment Services Luke Howarth
30 AUG: Transcript of speech to National Mental Health Youth Summit August 24-26
Subjects: Young Australians, Employment, Mental health, Housing, School, National Youth Policy Framework
Assistant Minister to the Attorney-General Amanda Stoker
30 AUG: Transcript of Interview with Jade Macmillan, ABC News
Subjects: COVID-19 restrictions, Border closures, Vaccinations, National Women's Summit, Financial support, Easing restrictions, Proof of vaccination
Leader of the Opposition Anthony Albanese
30 AUG: Transcript of Interview with Marcus Paul, 2SM
Subjects: National plan to reopen, COVID outbreaks around Australia, Lockdowns, Vaccine rollout, Quarantine facilities, Doherty modelling, Hospitals, Federal election, Newspoll
Minister for Health and Aged Care Greg Hunt
29 AUG: Transcript of Interview with Kieran Gilbert, Sky News
Subjects: COVID-19, Lockdown, NSW, Victoria, Vaccine rollout, Immunisation, Mental health, Youth, Public health, PM, Epidemiologist
Minister for Health and Aged Care Greg Hunt and Minister for Education and Youth Alan Tudge
27 AUG: Transcript of Press Conference with CHO, Professor Paul Kelly, and Head of Operation COVID Shield, Lieutenant General Frewen, Canberra
Subjects: Updated COVID-19 vaccine advice, ATAGI, Young people
Member for Fisher Andrew Wallace and Member for Canberra Alicia Payne
27 AUG: Transcript of Interview with Danica De Giorgio, Sky News Afternoon Agenda
Subjects: Vaccination thresholds, Doherty modelling, Situation in Afghanistan, National Cabinet, ATAGI advice, Delta variant
Senator for NSW Tim Ayres
27 AUG: Transcript of Interview with Chris Dover, 2WEB Outback Radio
Subjects: COVID-19, Lockdown, Vaccination, Immunisation, Western NSW, First Nations people, Pandemic, Closing the Gap, Regional Australia
Return to top
Reports
2020 Aged Care Workforce Census Report
Department of Health
This report presents the findings of the 2020 Aged Care Workforce Census (Census) conducted by the Australian Government Department of Health (Department). It follows four previous similar reports on workforce data in 2003, 2007, 2012 and 2016.
Download
COVID-19 vaccine weekly safety report
Department of Health
Vaccination against COVID-19 is the most effective way to reduce deaths and severe illness from infection. Two COVID-19 vaccines are currently in use in Australia - Vaxzevria (AstraZeneca) and Comirnaty (Pfizer). Recently, the Therapeutic Goods Administration (TGA) granted provisional approval for another vaccine called Spikevax (Moderna). To 29 August 2021, over 19 million vaccine doses have been given in Australia - approximately 12 million first doses and 7 million second doses.
Download
COVID-19 restriction tracker: As of announcements at 1600 hours 2 September 2021
Department of Health
Download
Pharmaceutical Benefits Advisory Committee (PBAC) Meeting Agenda - November 2021 PBAC Meeting
Department of Health
Download
What are the rules on using new animal test data
Department of Health
Download
Experimental hospital multifactor productivity estimates
Australian Bureau of Statistics (ABS)
Productivity measures are useful to assess the performance and efficiency of resource use. The ABS currently compiles multifactor productivity estimates for market sector industries but not for nonmarket sector industries such as health care. Non-market sector industries have a large portion of output provided at prices that are not economically significant; that is, where goods and services are provided to final consumers at prices below the cost of provision, such as public hospital services. Given the importance of non-market industries to the Australian economy, the ABS has a research agenda to address this gap in productivity statistics. This paper presents experimental estimates of multifactor productivity for hospitals, a sub-division of the health and social assistance industry.
Download
Fourth Progress Report
Royal Commission Into Violence, Abuse, Neglect & Exploitation of People With Disability
This is the Fourth progress report of the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability. It covers the six months from 1 January to 30 June 2021. The Royal Commission carried out a full program of activities during the reporting period. The Commission held public hearings and private sessions, and again expanded community engagement.
Download
Hearing health outreach services for Aboriginal and Torres Strait Islander children in the Northern Territory - July 2012 to December 2020
Australian Institute of Health & Welfare (AIHW)
Ear and hearing health is vital for overall health and quality of life. Ear disease and associated hearing loss can have long-lasting impacts on education, wellbeing and employment. Aboriginal and Torres Strait Islander children are more likely than non-Indigenous children to experience ear and hearing problems. A number of factors contribute to the poorer ear and hearing health of Indigenous children, including lack of access to health services, household overcrowding and second-hand smoke exposure.
Download
Indigenous eye health measures 2021
Australian Institute of Health & Welfare (AIHW)
This publication and the accompanying web report are part of a series of annual reports that update the Indigenous eye health measures. This report includes comprehensive eye health data at the national, state and regional levels. The report covers the prevalence of vision impairment and blindness; diagnosis and screening; treatment; workforce; and outreach programs. The report provides an evidence base for monitoring changes in Aboriginal and Torres Strait Islander eye health over time, access to and use of eye health services, and for identifying gaps in service delivery.
Download
Practice Incentives Program Quality Improvement Measures: National report on the first year of data 2020-21 - Report
Australian Institute of Health & Welfare (AIHW)
This is the first annual report on the 10 PIPQI measures. This report aims to provide nationally consistent, comparable data against specified measures that contribute to the assessment of needs, and to the improvement of regional and national health outcomes. The data, shared at the community level, and collected through the PIPQI Incentive, has the potential to inform primary health providers how to improve care and services to clients and within a population.
Download
Geographical analysis of hospitalised injury and injury deaths data, 2017-18
Australian Institute of Health & Welfare (AIHW)
This report presents interactive maps and data visualisations based on counts and rates of hospitalised injury and injury deaths by remoteness of usual residence for Australian jurisdictions in 2017-18. Overall, rates of injury hospitalisations and deaths rise with increasing remoteness. Transport accidents and assaults/homicide show the strongest relationship between increasing remoteness and increasing rates of deaths and hospitalisations.
Download
Pedal cyclist hospitalisations: estimating on-road cases: Technical report 2000-01 to 2017-18
Australian Institute of Health & Welfare (AIHW)
This technical report examines the effects of using the Traffic and Place approaches to specify pedal cyclist road injury cases when using data from the National Hospital Morbidity Database (NHMD), which have been coded according to the Australian clinical modification of the 10th revision of International Classification of Diseases (ICD-10-AM) (ACCD 2017).
Download
TAS: Public Health Act 1997 - Direction under Section 16 - Mandatory Vaccination of Certain Workers - No. 1
Tasmanian Department of Health
On and after 17 September 2021, the following persons are not permitted to enter, or remain on, the premises of a residential aged care facility unless the person is sufficiently vaccinated.
Download
Return to top
Hansards
Federal
02 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19
02 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19: Schools
02 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19: Hospitals
02 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19: National Plan
02 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19: Quarantine
02 SEP 2021: REPS HANSARD: Statements By Members - COVID-19: Victoria
02 SEP 2021: REPS HANSARD: Adjournment - COVID-19: Vaccination
02 SEP 2021: REPS HANSARD: Statements By Members - COVID-19
02 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19: Lockdowns
02 SEP 2021: REPS HANSARD: Statements By Members - Veterans: Mental Health
02 SEP 2021: SENATE NOTICE PAPER: Questions on Notice - 4080 Senator Keneally: Minister for Health and Aged Care - Question regarding vaccine information sessions/vaccine education seminars
01 SEP 2021: REPS HANSARD: Statements By Members - COVID-19: Testing and Detection
01 SEP 2021: REPS HANSARD: Statements By Members - COVID-19: Vaccination
01 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
01 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19: National Plan
01 SEP 2021: REPS HANSARD: Statements By Members - COVID-19
01 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19: Regional Australia
01 SEP 2021: REPS HANSARD: Questions Without Notice - COVID-19: Quarantine
01 SEP 2021: REPS HANSARD: Bills - Aged Care and Other Legislation Amendment (Royal Commission Response No. 2) Bill 2021 - First Reading, Second Reading, Debate Adjourned
01 SEP 2021: REPS HANSARD: Statements By Members - COVID-19: Quarantine
01 SEP 2021: REPS HANSARD: Bills - National Health Amendment (Decisions under the Continence Aids Payment Scheme) Bill 2021 - Second Reading, Third Reading
01 SEP 2021: SENATE HANSARD: Documents - COVID-19 Vaccination Certificates, COVID-19: Vaccination - Order for the Production of Documents
01 SEP 2021: SENATE HANSARD: Questions Without Notice - Western Australia: COVID-19
01 SEP 2021: SENATE HANSARD: Adjournment - Women's Health Week, National Summit on Women's Safety
01 SEP 2021: SENATE HANSARD: Questions Without Notice - COVID-19: Indigenous Health
01 SEP 2021: SENATE HANSARD: Bills - Aged Care Amendment (Registered Nurses Ensuring Quality Care) Bill 2021 - First Reading, Second Reading, Debate Adjourned
01 SEP 2021: SENATE HANSARD: Statements - COVID-19
01 SEP 2021: SENATE HANSARD: Statements - Human Immunodeficiency Virus
01 SEP 2021: SENATE HANSARD: Bills - National Health Amendment (COVID-19) Bill 2021 - First Reading, Second Reading, Debate Adjourned
01 SEP 2021: SENATE NOTICE PAPER: Questions on Notice - 4072 Senator Kitching: Minister for the National Disability Insurance Scheme - With reference to recent comments, how is obesity defined and quantified by the National Disability Insurance Scheme
30 AUG 2021: REPS HANSARD: Petitions - Responses - Private Health Insurance
30 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Mental Health
30 AUG 2021: REPS HANSARD: Statements By Members - Broadcasting Regulations - Afghanistan - COVID-19: Vaccination
30 AUG 2021: REPS HANSARD: Statements By Members - Curtin Electorate: Aged-Care and Disability Services
30 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Lockdowns
30 AUG 2021: REPS HANSARD: Questions Without Notice: Additional Answers - COVID-19: Lockdowns
30 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Mental Health
Queensland
02 SEP 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Coronavirus, Update - Coronavirus, Vaccination
02 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Coronavirus, Health Advice
02 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Caboolture Hospital, Surgery
02 SEP 2021: QLD ASSEMBLY HANSARD: Committees - Health and Environment Committee - Report
02 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Coronavirus, Child Vaccination
02 SEP 2021: QLD ASSEMBLY HANSARD: Bills - Public Health and Other Legislation (Further Extension of Expiring Provisions) Amendment Bill 2021 - Debate Resumed, Second Reading, Consideration in Detail, Message from Deputy Governor, Third Reading, Long Title
02 SEP 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Coronavirus, Economy
02 SEP 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Coronavirus, Update
02 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Spinal Muscular Atrophy, Newborn Screening
02 SEP 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Coronavirus, Vaccination
02 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Coronavirus, Queensland Border Restrictions
02 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Moreton Bay Islands, Ambulance Services
02 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Coronavirus, Economic Recovery
02 SEP 2021: QLD ASSEMBLY HANSARD: Private Members' Statements - Coronavirus, Queensland Border Restrictions
02 SEP 2021: QLD ASSEMBLY HANSARD: Adjournment - Toowoomba, Quarantine Facility
02 SEP 2021: QLD ASSEMBLY HANSARD: Adjournment - Coronavirus, Vaccination Hubs
02 SEP 2021: QLD ASSEMBLY HANSARD: Private Members' Statements - Coronavirus
01 SEP 2021: QLD ASSEMBLY HANSARD: Adjournment - Sexual Health Education
01 SEP 2021: QLD ASSEMBLY HANSARD: Adjournment - Gympie - Health Services
01 SEP 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Coronavirus - Vaccination
01 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Coronavirus - Vaccination
01 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - First Nations People - Coronavirus Vaccination
01 SEP 2021: QLD ASSEMBLY HANSARD: Bills - Public Health and Other Legislation (Further Extension Of Expiring Provisions) Amendment Bill 2021 - Second Reading, Debate Adjourned
01 SEP 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Caboolture Hospital - Patient Safety
01 SEP 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Coronavirus - Update
01 SEP 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Satellite Hospitals
Western Australia
02 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Vaccination Plan - Regions
02 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Mental Health Co-Response Team - Geraldton
02 SEP 2021: WA COUNCIL HANSARD: Questions on Notice - Medical Cannabis - Pharmaceutical Benefits Scheme
02 SEP 2021: WA COUNCIL HANSARD: Questions on Notice - Police - Cannabis Offences
02 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Health - 2021-22 State Budget
02 SEP 2021: WA COUNCIL HANSARD: Motion - Cannabis - Research
02 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - First Responders - Mental Health Support
02 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Interstate Border Restrictions - Victoria
02 SEP 2021: WA COUNCIL HANSARD: Statement - Women and Infants Research Foundation
02 SEP 2021: WA COUNCIL HANSARD: Statement - Medical Cannabis
02 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - King Edward Memorial Hospital for Women - Midwives
02 SEP 2021: WA COUNCIL HANSARD: Question Without Notice 606 - Answer Advice - Healthcare Worker Immunisation Policy
02 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Hospitals - Maternity Bypasses
02 SEP 2021: WA COUNCIL HANSARD: Statement - Prostate Cancer Awareness Month
01 SEP 2021: WA COUNCIL HANSARD: Questions on Notice - School Health Nurses
01 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Leading Causes of Death Statistics
01 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Police - Mental Health Support Services
01 SEP 2021: WA COUNCIL HANSARD: Questions on Notice - Health - Dongara Health Centre Redevelopment
01 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Healthcare Worker Immunisation Policy
01 SEP 2021: WA COUNCIL HANSARD: Statement - Childhood Cancer Awareness Month
01 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Vaccinations - Mining and Pastoral Region
01 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Albany Health Campus - Bed Capacity
01 SEP 2021: WA COUNCIL HANSARD: Questions Without Notice - Medical Cannabis - MGC Pharmaceuticals
Return to top
Court Cases
None this edition.
Return to top
New Regulations
Federal
Health Insurance (Extended Medicare Safety Net) Amendment (Repetitive Transcranial Magnetic Stimulation Capping) Determination 2021
Legislative Instrument - F2021L01230
The purpose of the Health Insurance (Extended Medicare Safety Net) Amendment (Repetitive Transcranial Magnetic Stimulation Capping) Determination 2021 (the EMSN Amendment Determination) is to amend the Health Insurance (Extended Medicare Safety Net) Determination 2017 (the Principal Determination) to apply an EMSN benefit cap to the rTMS items from 1 November 2021.
Explanatory Statement
National Health (Electronic National Residential Medication Chart Trial) Amendment (Approved Residential Care Services) Special Arrangement 2 of 2021
Legislative Instrument - F2021L01227
The Principal Instrument allows electronic medication management software vendors to trial their electronic medication order chart systems for the purposes of the Pharmaceutical Benefits Scheme (PBS) within a number of approved residential care services (as identified in the Schedule to the Principal Instrument). These systems provide a fully electronic version of the paper based residential medication chart currently available in all Australian approved residential care services.
Explanatory Statement
Biosecurity (Human Biosecurity Emergency) (Human Coronavirus with Pandemic Potential) Variation (Extension No. 3) Instrument 2021
Legislative Instrument - F2021L0123
The purpose of the Biosecurity (Human Biosecurity Emergency) (Human Coronavirus with Pandemic Potential) Variation (Extension No.3) Instrument 2021 (the Instrument) is to vary the Declaration to extend the human biosecurity emergency period for a further three months until 17 December 2021.
Explanatory Statement
National Health (Pharmaceutical Benefits Scheme- Exempt items - Section 84AH) Amendment Determination 2021 (No. 3)
Legislative Instrument - F2021L01222
The purpose of this legislative instrument, made under section 84AH of the National Health Act 1953 (the Act), is to amend the legislative instrument titled National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84 AH) Determination 2017 (PB 81 of 2017) to make changes to the pharmaceutical items that are determined to be exempt items.
Explanatory Statement
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (September Update) Instrument 2021
Legislative Instrument - F2021L01221
This is the National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (September Update) Instrument 2021 (PB 91 of 2021) (this Instrument). The purpose of this Instrument, made under subsection 100(2) of the Act, is to amend the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021) (the Special Arrangement), to make changes to the Special Arrangement relating to the Highly Specialised Drugs Program.
Explanatory Statement
National Health (Pharmaceutical benefits - early supply) Amendment Instrument 2021 (No. 8)
Legislative Instrument - F2021L01219
The purpose of this legislative instrument, made under subsection 84AAA(2) of the National Health Act 1953 (the Act) is to amend the National Health (Pharmaceutical benefits-early supply) Instrument 2015 (PB 120 of 2015) (the Principal Instrument). PB 120 of 2015 specifies the pharmaceutical items that are in pharmaceutical benefits for which Pharmaceutical Benefits Scheme (PBS) safety net entitlements will not apply for early supplies, and to specify the period following previous supply. The amendments made by this Instrument reflect amendments to the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012), which commence on the same day. The National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012) is made under sections 84AF, 84AK, 85, 85A, 88 and 101 of the Act.
Explanatory Statement
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 8)
Legislative Instrument - F2021L01218
The purpose of this legislative instrument, made under sections 84AF, 84AK, 85, 85A, 88 and 101 of the National Health Act 1953 (the Act), is to amend the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012) to make changes to the pharmaceutical benefits listed on the Pharmaceutical Benefits Scheme (PBS) and related matters. PB 71 of 2012 determines the pharmaceutical benefits that are on the PBS through declarations of drugs and medicinal preparations, and determinations of forms, manners of administration and brands. It also provides for related matters (equivalent brands, responsible persons, prescribing circumstances, maximum quantities, number of repeats, determined quantity and pack quantity, section 100 only status and prescriber bag only status).
Explanatory Statement
National Health (Listed Drugs on F1 or F2) Amendment Determination 2021 (No. 6)
Legislative Instrument - F2021L01217
This instrument makes amendments to the Principal Determination. The Act provides that PBS listed drugs may be assigned to formularies identified as F1 and F2. F1 is intended for single branded drugs and F2 for drugs that have multiple brands, or are in a therapeutic group with other drugs with multiple brands. Drugs on F2 are subject to the provisions of the Act relating to price disclosure and guarantee of supply. Section 84AC of the Act provides that a drug is on F1 or F2 if there is a determination in force under section 85AB that the drug is on F1 or F2.
Explanatory Statement
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2021 (No. 8)
Legislative Instrument - F2021L01215
The purpose of this Instrument, made under subsection 100(2) of the Act, is to amend the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011) (the Special Arrangement) to make changes relating to the Efficient Funding of Chemotherapy. The Special Arrangement achieves greater efficiency in payment for the supply of injected or infused chemotherapy medicines ('chemotherapy pharmaceutical benefits') to eligible patients being treated for cancer, to reflect the 2010 Budget measure titled 'Revised arrangements for the efficient funding of chemotherapy drugs'. The Special Arrangement also relates to the supply of medicines associated with the side-effects of cancer and cancer treatment ('related pharmaceutical benefits') at certain public hospitals.
Explanatory Statement
National Health (Continued Dispensing - Emergency Measures) Amendment Determination 2021 (No. 8)
Legislative Instrument - F2021L01214
The purpose of this legislative instrument, made under subsection 89A(3) of the National Health Act 1953 (the Act), is to amend the National Health (Continued Dispensing - Emergency Measures) Determination 2020 to make changes to the pharmaceutical benefits eligible to be provided as a Continued Dispensing supply. The National Health (Continued Dispensing - Emergency Measures) Determination 2020 (the Principal Instrument) expands the list of pharmaceutical benefits that can be supplied by an approved pharmacist under Part VII of the Act without a prescription, and provides the conditions for such a supply (a 'Continued Dispensing' supply).
Explanatory Statement
National Health (Weighted average disclosed price - October 2021 reduction day) Amendment Determination 2021
Legislative Instrument - F2021L01195
This legislative instrument amends the National Health (Weighted average disclosed price - October 2021 reduction day) Determination 2021 (PB 72 of 2021) (the Principal Instrument) by:
- removing from Schedule 1 and inserting in Schedule 2 WADPs for brands of pharmaceutical items containing:
- pegfilgrastim, injection 6 mg in 0.6 mL single use pre-filled syringe, injection;
- clonidine, tablet containing clonidine hydrochloride 100 micrograms, oral and;
- clonidine, tablet containing clonidine hydrochloride 150 micrograms, oral.
Explanatory Statement
New South Wales
27 AUG 2021: NSW, CONSTANCE: Legislation - Regulations and other miscellaneous instruments - Passenger Transport (General) Amendment (Drug and Alcohol Testing) Regulation 2021 - Passenger Transport Act 1990 - 2021-483
Tasmania
02 SEP 2021: TAS, ROCKLIFF: Ambulance Service (Fees) Regulations 2021 - Statutory Rules 2021, No. 69
Victoria
31 AUG 2021: VIC, STITT: Occupational Health and Safety Amendment (Major Hazard Facilities) Regulations 2021 - S.R. No. 112/2021
Return to top
Proclamations
None this edition.
Return to top
Gazette Notices
New South Wales
01 SEP 2021: NSW GOVERNMENT GAZETTE No. 425: Government Notices - Health and Education
31 AUG 2021: NSW GOVERNMENT GAZETTE No. 423: Government Notices - Health and Education
27 AUG 2021: NSW GOVERNMENT GAZETTE No. 419: Government Notices - Health and Education
27 AUG 2021: NSW GOVERNMENT GAZETTE No. 414: Government Notices - Health and Education
26 AUG 2021: NSW GOVERNMENT GAZETTE No. 411: Extraordinary Gazette - Public Health Act 2010 - Public Health (COVID-19 Vaccination of Health Care Workers) Order 2021
25 AUG 2021: NSW GOVERNMENT GAZETTE No. 409 - Government Notices - Health and Education
Return to top
Consolidated Legislation
Health Insurance (Section 3C General Medical - Expansion of GP and Allied Health Mental Health Services) Determination 2020
Legislative Instrument Compilation - F2021C00877
Determinations/Health as amended, taking into account amendments up to Health Insurance Legislation Amendment (Section 3C General Medical Services - Cease GP Mental Health Treatment Plan Phone Services) Determination 2021.
Download
Subsidy Principles 2014
Legislative Instrument Compilation - F2021C00873
Principles as amended, taking into account amendments up to Aged Care Legislation Amendment (Improved Home Care Payment Administration) Instrument 2021.
Download
National Health (Medication Program for Homeless People) Special Arrangement 2021
Legislative Instrument Compilation - F2021C00872
PB 73 of 2021 Arrangements as amended, taking into account amendments up to National Health (Medication Program for Homeless People) Amendment Special Arrangement 2021.
Download
National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021
Legislative Instrument Compilation - F2021C00868
PB 84 of 2021 Determinations/Health as amended, taking into account amendments up to National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 1) Determination 2021.
Download
National Health (Listing of Pharmaceutical Benefits) Instrument 2012
Legislative Instrument Compilation - F2021C00866
PB 71 of 2012 Other as amended, taking into account amendments up to National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 7).
Download
User Rights Principles 2014
Legislative Instrument Compilation - F2021C00861
Principles as amended, taking into account amendments up to Aged Care Legislation Amendment (Improved Home Care Payment Administration) Instrument 2021.
Download
Therapeutic Goods (Medical Devices) Regulations 2002
Legislative Instrument Compilation - F2021C00856
SR 2002 No. 236 Regulations as amended, taking into account amendments up to Therapeutic Goods Legislation Amendment (2021 Measures No. 2) Regulations 2021
Download
Health Insurance (Section 3C General Medical Services - COVID-19 Telehealth and Telephone Attendances) Determination 2020
Legislative Instrument Compilation - F2021C00849
Determinations/Health as amended, taking into account amendments up to Health Insurance Legislation Amendment (Section 3C General Medical Services - GP Mental Health Treatment Plan Review) Determination (No. 2) 2021.
Download
Return to top
New Bills
Federal
A Private Member's Bill (Patrick) for an Act to amend the Aged Care Act 1997, and for related purposes.
The Bill amends the Aged Care Act 1997 to require all approved aged care facilities to have at least one registered nurse on duty at all times within an aged care facility. The registered nurse will be required to provide care and supervise the provision of care to residents of an approved aged care facility.
Currently in Australia, there is no nationwide requirement that nursing homes must have at least one registered nurse on duty at all times as confirmed by the recent Royal Commission into Aged Care Quality and Safety. This inconsistent approach leads to variations on the level of care and quality afforded to residents and negatively impacts the working lives of staff providing that care within Australia.
Senate: Intro 01/09/21, 2R 01/09/21, Passed TBA
Reps: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: The whole of this Act: The day after this Act receives the Royal Assent.
A Bill for an Act to amend the law relating to aged care, health and aged care pricing, and information sharing in relation to veterans and military rehabilitation and compensation, and for related purposes
Schedule 1 amends the Aged Care Act 1997 (Aged Care Act) and the Aged Care (Transitional Provisions) Act 1997 (Transitional Act) to enable the introduction of a new residential aged care basic subsidy calculation model, the Australian National Aged Care Classification (AN-ACC). This model will replace the Aged Care Funding Instrument from 1 October 2022. The new funding model will link calculation of a variable amount of residential aged care subsidy to each care recipient's AN-ACC level. It will also link calculation of a fixed amount of subsidy to the characteristics of residential aged care services. This fixed component will be the same for all residents at a service and will be higher for services in remote locations and certain specialist services, in recognition of higher fixed operating costs.
Schedule 2 of the Bill amends the Aged Care Act and the Aged Care Quality and Safety Commission Act 2018 (Quality and Safety Commission Act) to establish the legislative authority for nationally consistent pre-employment screening for aged care workers of approved providers to replace existing police checking obligations.
Schedule 3 of the Bill amends the Aged Care Act and the Quality and Safety Commission Act to allow the Aged Care Quality and Safety Commissioner (Commissioner) to make and enforce a Code of Conduct (Code) that will apply to approved providers and their workers, including governing persons. It will give the Commissioner powers to deal with information received about alleged breaches of the Code, and take enforcement actions for substantiated breaches.
Schedule 4 of the Bill amends the Aged Care Act to extend the Serious Incident Response Scheme (SIRS) from residential care to home care and flexible care delivered in a home or community setting from 1 July 2022. This Schedule introduces new responsibilities for approved providers of home care, and flexible care delivered in a home or community setting to manage incidents, including through implementing and maintaining an incident management system that complies with requirements set out in the Quality of Care Principles 2014.
The definition of a reportable incident will also be extended to home and community care settings, so that home care and flexible care providers operating in these settings will be required to notify the Commissioner of these incidents. Protections against retribution or vilification for individuals reporting such incidents will also extend to reportable incidents in these settings.
Schedule 4 of the Bill will also amend the Quality and Safety Commission Act to expand the Commissioner's powers to deal with incidents that are reported by Commonwealth grant funded aged care service providers, and authorise these providers to collect, use and disclose information relevant to their obligations in relation to the SIRS for the purposes of the Privacy Act 1988.
Schedule 5 of the Bill amends the Aged Care Act and the Quality and Safety Commission Act to improve the governance of approved providers of aged care. From 1 March 2022, the amendments will introduce new governance responsibilities for approved providers in relation to the membership of their governing bodies and the establishment of new advisory bodies, as well as measures to improve leadership and culture. These measures are aimed at improving transparency and accountability, and ensuring the focus of approved providers, from the top down, is on the best interests of care recipients.
Schedule 5 also introduces new reporting responsibilities for approved providers, including to provide an annual statement on their operations that will be made publicly available. This will help care recipients and their families understand key details of providers, including information about financial circumstances, staffing levels and complaints. The amendments will also require approved providers to notify the Commission of changes to key personnel and will replace the current disqualified individual arrangements with a suitability test for key personnel, consistent with the arrangements under the National Disability Insurance Scheme (NDIS).
Schedule 6 of the Bill amends the Aged Care Act, the Quality and Safety Commission Act, Veterans' Entitlements Act 1986, the Military Rehabilitation and Compensation Act 2004, and the Safety, Rehabilitation and Compensation (Defence-related Claims) Act 1988 to facilitate greater information sharing between Commonwealth bodies across the aged care, disability and veterans' affairs sectors in relation to noncompliance of providers and their workers.
Schedule 7 of the Bill amends the Aged Care Act to enable the Secretary or Commissioner to request information or documents from a provider or borrower of a loan made using a refundable accommodation deposit or bond. The amendments create an offence for a borrower who does not comply with a request. Further, the period of liability for the existing offences for the misuse of refundable accommodation deposits prior to an insolvency event for both providers and key personnel of providers will be extended from 2 years to 5 years.
Schedule 7 also amends the Quality and Safety Commission Act to enable the Commissioner to issue an infringement notice for a borrower who commits an offence for failing to comply with a request under these amendments. The reforms implemented under Schedule 7 of the Bill will form part of the second phase of a three phase plan to implement a new financial and prudential monitoring, compliance and intervention framework for the aged care sector.
Schedule 8 to the Bill amends the National Health Reform Act 2011 (National Health Reform Act) and the Aged Care Act to expand the functions of a renamed Independent Health and Aged Care Pricing Authority (Pricing Authority) to include the provision of advice on health care pricing and costing matters, provision of advice on aged care pricing matters and the performance of certain functions conferred in the Aged Care Act. The amendments also establish new governance arrangements and appointments processes for the Pricing Authority. The new governance and appointment arrangements will reflect the enhanced responsibilities and integrated functions of the Pricing Authority and streamline its administration.
Schedule 8 also amends the National Health Reform Act, the Aged Care Act and the Quality and Safety Commission Act to ensure appropriate use and disclosure of information required for the Pricing Authority to perform its new functions.
Reps: Intro 01/09/21, 2R 01/09/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedule 1 - 1 October 2022.
- Schedule 2 - A single day to be fixed by Proclamation. However, if the provisions do not commence within the period of 12 months beginning on the day this Act receives the Royal Assent, they commence on the day after the end of that period.
- Schedule 3 - 1 July 2022.
- Schedule 4, Part 1 - 1 July 2022.
- Schedule 4, Part 2 - The day after this Act receives the Royal Assent.
- Schedule 5 - 1 March 2022.
- Schedule 6 - The day after this Act receives the Royal Assent.
- Schedule 7 - 1 July 2022.
- Schedule 8 - The 28th day after this Act receives the Royal Assent.
A Bill for an Act to amend the Biosecurity Act 2015, and for related purposes
The Bill will amend the Biosecurity Act 2015 (the Biosecurity Act) to enhance the ability to manage the risk of pests and diseases entering, emerging, establishing or spreading in Australian territory and causing harm to animal, plant and human health, the environment and the economy. It will strengthen the operation of the biosecurity framework through improving efficiency and effectiveness of the administration of the Biosecurity Act, increase a range of civil and criminal penalties to deter non-compliance and strengthen the identification and management of biosecurity risks posed by maritime and aviation arrivals.
The Biosecurity Act provides the regulatory framework for the management of risks of pests and diseases entering Australian territory and gives effect to Australia's relevant international rights and obligations.
The Bill amends the Biosecurity Act to:
- Strengthen pratique and human health requirements by:
- expanding pre-arrival reporting requirements for aircraft and vessels;
- strengthening penalties for non-compliance with negative pratique requirements; and
- creating a mechanism to make a human biosecurity group direction;
- Increase civil and criminal penalties for contraventions of Chapter 3 of the Biosecurity Act, which deals with managing biosecurity risks in relation to goods;
- Streamline the process for making certain determinations specifying prohibited, conditionally non-prohibited and suspended goods or granting permits based on risk assessments; and
- Increase efficiency and ensure transparency of expenditure on biosecurity-related programs and activities by permitting the Agriculture Minister and Health Minister to authorise the expenditure directly through the Biosecurity Act.
On 2 September 2021, the Senate Selection of Bills Committee referred the Bill to the Rural and Regional Affairs and Transport Legislation Committee for inquiry and report by 14 October 2021.
Reps: Intro 01/09/21, 2R 01/09/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedule 1 - A single day to be fixed by Proclamation. However, if the provisions do not commence within the period of 6 months beginning on the day this Act receives the Royal Assent, they commence on the day after the end of that period.
- Schedules 2 to 4 - The day after this Act receives the Royal Assent.
A Bill for an Act to amend the Dental Benefits Act 2008, and for related purposes
This Bill will amend the Dental Benefits Act 2008 (the Act) to remove the lower eligibility age restriction of 2 years to allow eligible children from 0 years of age to access the Child Dental Benefits Schedule (CDBS).
The CDBS operates under the Act to provide eligible children aged between 2-17 years access to up to $1,013 in benefits for basic dental services, with benefits capped over two consecutive calendar years. The CDBS has provided over $2.3 billion in benefits and delivered more than 38 million services to over 3 million Australian children since it commenced on 1 January 2014 (to 30 June 2021).
The Report on the Fourth Review of the Dental Benefits Act 2008 (the Review) recommended lowering the current eligibility age to one year of age. The feedback received by the Department from the key stakeholders advised their preference of removing the lower eligibility age restriction altogether enabling all children under 18 years of age to access the scheme if they meet the CDBS means test requirements.
By removing the lower eligibility age restriction altogether, it is estimated that each year an additional 300,000 children aged between 0 and 2 will become eligible for the program from 1 January 2022. It is estimated that each year 15% of children in this newly eligible age group (presenting with teeth) will access the scheme.
Reps: Intro 04/08/21, 2R 04/08/21, 11/08/21, 12/08/21, 26/08/21, Passed 26/08/21
Senate: Intro 31/08/21, 2R 31/08/21, Passed TBA
Assent TBA, Act No. TBA
Commencement: The whole of this Act - 1 January 2022.
A Bill for an Act to amend the National Health Act 1953, and for related purposes.
The Bill provides the Minister for Health with the power to enter into arrangements and make payments in relation to procuring COVID-19 vaccines, inclusive of boosters, and necessary consumables, and COVID-19 treatments.
Reps: Intro 26/08/21, 2R 26/08/21, 31/08/21, Passed 31/08/21
Senate: Intro 01/09/21, 2R 01/09/21, 02/09/21, Passed 02/09/21
Awaiting assent
Assent TBA, Act No. TBA
Commencement: The whole of this Act - The day this Act receives the Royal Assent.
A Bill for an Act to amend the National Health Act 1953, and for related purposes.
The purpose of the Bill is to provide express support for the Continence Aids Payment Scheme (CAPS) to confer review functions on the Administrative Appeals Tribunal (AAT). The Bill amends the National Health Act 1953 to provide that a legislative instrument made under section 12 of the Act may provide that applications may be made to the AAT for review of decisions made in exercise of powers conferred by the instrument.
Senate: Intro 16/06/21, 2R 16/06/21, 05/08/21, Passed 05/08/21
Reps: Intro 05/08/21, 2R 01/09/21, Passed 01/09/21
Assent TBA, Act No. TBA
Commencement: The whole of this Act: The day after this Act receives the Royal Assent.
A Private Member's Bill (Kelly) for an Act to implement Article 6 of the Universal Declaration on Bioethics and Human Rights, and for related purposes
The purpose of the Bill to ensure that Australia complies with provisions of article 6.1 of the Universal Declaration on Bioethics and Human Rights
Reps: Intro 30/08/21, 2R 30/08/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: The whole of this Act - The day after this Act receives the Royal Assent.
Queensland
A Bill for An Act to amend the Body Corporate and Community Management Act 1997, the Corrective Services Act 2006, the COVID-19 Emergency Response Act 2020, the Economic Development (COVID-19 Emergency Response) Regulation 2020, the Environmental Protection Act 1994, the Explosives Legislation (COVID-19 Emergency Response) Regulation 2020, the Gaming Machine Act 1991, the Health Legislation (COVID-19 Emergency Response) Regulation 2020, the Justice and Other Legislation (COVID-19 Emergency Response) Amendment Act 2020, the Mental Health Act 2016, the Public Health Act 2005, the Public Health and Other Legislation (Extension of Expiring Provisions) Amendment Act 2021 and the Public Health and Other Legislation (Public Health Emergency) Amendment Act 2020 for particular purposes.
The Bill achieves the policy objectives by extending essential measures supporting Queensland's response to the COVID-19 pandemic until 30 April 2022 and refining some of these measures given the changing nature of the pandemic and knowledge gained from implementation.
Intro 16/06/21, Referred to Health and Environment Committee 16/06/21, Report tabled 06/08/21, 2R 01/09/21, 02/09/21, Passed (with amendments) 02/09/21
Assent TBA, Act No. TBA
Commencement: This Act commences on the day this Act receives the Royal Assent, except that -
(1) Part 11, division 3 commences on 1 October 2021.
(2) Part 12, division 3 commences on a day to be fixed by proclamation.
Return to top
New Acts
Federal
Australian Organ and Tissue Donation and Transplantation Authority Amendment (Governance and Other Measures) Act 2021
An Act to amend the Australian Organ and Tissue Donation and Transplantation Authority Act 2008, and for related purposes
This Act will amend the Australian Organ and Tissue Donation and Transplantation Authority Act 2008 (OTA Act) to transition the role of the Accountable Authority under the Public Governance, Performance and Accountability Act 2013 (PGPA Act) from the Board to the Chief Executive Officer (CEO). This change follows recommendations made by Dr Mal Washer, Chair of the Organ and Tissue Authority Board (the Board), to Minister Coulton to enable the Board to have a more strategic and advisory focus. This amendment will repeal the existing Board and create a new Advisory Board.
Reps: Intro 16/06/21, 2R 16/06/21, 11/08/21, Passed 11/08/21
Senate: Intro 12/08/21, 2R 12/08/21, 26/08/21, Passed 26/08/21
Assent 02/09/21, Act No. 89 of 2021
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedules 1 and 2 - A single day to be fixed by Proclamation. However, if the provisions do not commence within the period of 6 months beginning on the day this Act receives the Royal Assent, they commence on the day after the end of that period.
Return to top